Case Study: Advancing Patient Access Through Early Engagement with Payers & the Cell & Gene Therapy Access Model
- Engaging payers early to educate on the product and disease state while generating appropriate outcomes to support contracting
- Building evidence of value to drive coverage while addressing reimbursement challenges for qualified treatment centres
- Showcasing substantial growth in patient adoption over two years, and outlining challenges that remain